
Home » NOVOZYMES, INC. ACQUIRES DELTA BIOTECHNOLOGY, LTD.
NOVOZYMES, INC. ACQUIRES DELTA BIOTECHNOLOGY, LTD.
Novozymes has acquired Delta Biotechnology Ltd from the sanofi-aventis group. Established in 1984, Delta is, from 6th July, a wholly-owned subsidiary of Novozymes A/S operating as a self-contained business unit with both its R&D and manufacturing facilities based in Nottingham, UK. The new company will operate under the name Novozymes Delta Ltd.
BioSpace
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb
-
07Mar